Sox9 encodes an HMG-domain transcription factor that is critically required in numerous developmental processes such as chondrogenesis and otic placode formation. Here, we show that Sox9 is expressed in the mesenchyme surrounding the developing cochlea in the mouse suggesting that Sox9 may also control development of the otic fibrocyte compartment and the surrounding otic capsule. Tissue-specific inactivation of Sox9 in the periotic mesenchyme using a Tbx18 Cre mouse line results in arrest of early chondrogenesis and consequently, in a lack of cochlear otic capsule formation. Furthermore, loss of Sox9 severely compromises expansion, differentiation and remodeling of the otic fibrocyte compartment. Early cell proliferation defects in the entire periotic mesenchyme of Sox9-deficient inner ears suggest a cell-autonomous function of Sox9 for the development of the inner mesenchymal compartment. Abnormal cochlear duct morphogenesis in Sox9 mutants including disruption of the coiling process is tightly associated with the onset of mesenchymal defects whereas the absence of major differentiation defects in the otic epithelium suggests that Sox9dependent mesenchymal signals primarily control epithelial morphogenesis.
Introduction
The mammalian inner ear contains the sensory organs for hearing and balance; the cochlea that perceives sound, and the vestibulum, with utricle and saccule and semicircular canals that measures torsion and linear acceleration. Unifying feature is the presence of specialized sensory cells, the hair cells that transform mechanical deflection into electrical signals, and forward them to associated neurons. Hair cells are arranged in a continuous epithelial cell layer interspersed with supporting cells that is surrounded by a layer of otic fibrocytes (termed inner compartment) and a protecting outer bony capsule (reviewed in Raphael and Altschuler (2003) ). Otic fibrocytes do not only serve as a mechanical link between the epithelial cell compartment and the otic capsule but they are also critically involved in the sensory process by maintaining the ionic homoeostasis required for hair cell depolarization (reviewed in Wangemann (2006) ).
Epithelial and mesenchymal compartments of the inner ear arise from distinct cell lineages during embryonic development. In the mouse, a specialized region of the surface ectoderm adjacent to the posterior hindbrain, the otic placode, starts to invaginate at E8.5 and detaches to form a vesicle, the otocyst, around E10.0. Subsequent epithelial morphogenesis generates the complex three-dimensional (3-D) architecture of the vestibulum and the coiled cochlea. Cells of the otocyst proliferate, migrate and differentiate to give rise to the neurons of the cochleovestibular ganglion and the epithelial sensory and non-sensory cells of the membraneous labyrinth (Kiernan et al., 2002; Barald and Kelley, 2004, and references therein) . Mesenchymal cells of cranial paraxial mesodermal origin start to condense around the otocyst at E10.0. The cells in direct proximity to the otic epithelium will differentiate into otic fibrocytes, whereas the outer compartment of mesenchymal cells will undergo endochondral ossification to form the bony capsule that envelopes the membranous labyrinth (Sher, 1971; McPhee and Van de Water, 1985; Cohen-Salmon et al., 2000) .
Tissue recombination and explant culture experiments in mice and birds suggest that the regular development of epithelial and mesenchymal compartments of the inner ear relies on intense reciprocal tissue interactions (McPhee and Van de Water, 1986; Swanson et al., 1990) . In particular, factors inducing and regulating chondrogenesis, including Fibroblast growth factors (Fgfs) 2,3 and 9, Transforming growth factor (Tgf)ß1 and Bone morphogenetic protein 4 (Bmp4) emanate from the otic epithelium (Frenz and Van De Water, 1991; Frenz et al., 1994; Frenz and Liu, 1998; Liu et al., 2003; Pirvola et al., 2004) . Conversely, the periotic mesenchyme is a source of signals that induce otic placode formation (Barald and Kelley, 2004) , and control patterning and differentiation of the sensory epithelium (Montcouquiol and Kelley, 2003; Doetzlhofer et al., 2004) . Experimental removal of the periotic mesenchyme decreases the morphogenetic potential of the epithelium indicating that cellular reorganizations underlying the cochlear coiling mechanism require an interaction with the surrounding mesenchyme (Miura et al., 2004) . However, the in vivo relevance of these findings and the nature of signaling factors and transcriptional circuits that mediate and interpret tissue interactions during inner ear development have remained elusive. Genetic analyses have recently identified the POU domain, class 3, transcription factor 4 (Pou3f4) and the T-box 1 protein (Tbx1) as potential regulators of these processes. Loss of Pou3f4 in the periotic mesenchyme results in mild defects of cochlear coiling morphogenesis (Minowa et al., 1999; Phippard et al., 1999) . In contrast, conditional inactivation of Tbx1, a T-box transcription factor implicated in the etiology of DiGeorge syndrome, from the periotic mesenchyme, results in a rudimentary cochlea with severely compromised coiling and disrupted differentiation of the Organ of Corti. These epithelial defects were interpreted to be secondary to the disruption of pericochlear capsule formation by decreased mesenchymal proliferation (Xu et al., 2007) .
Sox9 encodes a transcription factor with a conserved SRY-related high mobility group (HMG) DNA binding domain (Foster et al., 1994; Wagner et al., 1994) . Sox9 is a critical regulator of chondrogenesis but a requirement in the development of many other organs has also been reported (Akiyama et al., 2002;  for summary Kist (2009) ). Homozygous loss of Sox9 leads to early embryonic lethality (Akiyama et al., 2004) . Heterozygous mice die perinatally and serve as a model for campomelic dysplasia, a human skeletal malformation syndrome that is frequently associated with conductive and sensorineural hearing loss (Tokita et al., 1979; Houston et al., 1983; Foster et al., 1994; Wagner et al., 1994; Bi et al., 2001; Mansour et al., 2002) .
In fact, studies in Xenopus and zebrafish have previously provided evidence for an additional primary function of Sox9 in inner ear development. Morpholino antisense oligonucleotide-mediated depletion of Sox9 protein in Xenopus embryos results in loss of early otic markers and failure of otic vesicle development. Expression of an inducible dominant negative version of Sox9 blocked otic development during gastrulation, but had little effect on later inner ear development, indicating that Sox9 is required for otic placode specification, but not for subsequent processes in otic development (Saint-Germain et al., 2004) . Furthermore, loss of Sox9a and Sox9b function in zebrafish results in the absence or severe reduction of the otic vesicle (Yan et al., 2005) , whereas over-expression of Sox9 in Xenopus causes the formation of enlarged or ectopic otic vesicles (Taylor and Labonne, 2005) .
Tissue-specific Sox9 inactivation in the early otic epithelium recently disproved a role in otic placode specification in the mouse, but suggested instead that Sox9 controls adhesive properties and invagination of placodal cells in a cell-autonomous manner (Barrionuevo et al., 2008) . The early arrest of inner ear development in this mouse model precludes investigation of an independent role of Sox9 in the periotic mesenchyme in which it is also expressed. Here, we use a Tbx18 Cre line to inactivate Sox9 specifically in the mesenchymal compartment of the inner ear. We show that Sox9 is not required for early condensation and compartmentalization of this tissue but for formation of the cartilaginous otic capsule in the outer compartment. Inactivation of Sox9 results in profound defects in expansion and differentiation of otic fibrocytes and cochlear duct morphogenesis revealing crucial tissue interactions between mesenchymal and epithelial compartments in the developing cochlea in vivo.
Material and methods

Mouse lines and embryo preparation
For the generation of a Cre Knock-in allele of Tbx18 (Tbx18 Cre , Tbx18 tm4(cre)Akis ) a targeting vector was constructed to insert into the Tbx18 locus a Cre ORF followed by a PGK-neo cassette flanked by FRT sites. After homologous recombination the ATG codon of Cre replaced the endogenous Tbx18 start codon, and a 0.8 kbp genomic fragment spanning from the ATG to a 3′-NotI site was deleted (Supplemental Fig. 1 ). The targeting vector was confirmed by restriction mapping and sequencing and linearized for electroporation into 129/SvImJ ES cells. 24 h after electroporation, selection of transgenic clones started by addition of 125 µg/ml G418 to the medium. Surviving colonies were expanded and genotyped by Southern blot similar to the generation of LacZ and Gfp knock-in alleles of Tbx18 (Bussen et al., 2004; Wiese et al., 2009) . Two of five verified ES clones with a homologous recombination event were microinjected into CD1 mouse morulae. Chimeric males were obtained and mated to a FLPe deleter line (Tg (ACTFLPe)9205Dym/J) (Rodriguez et al., 2000) to produce F1 animals with the neo cassette removed. Tbx18 Cre , Sox9 flox (Sox9 tm1Gsr ) (Kist et al., 2002) and Rosa26 LacZ (Gt(ROSA)26Sor) (Soriano, 1999) mice were maintained on an NMRI outbred background. Embryos for Sox9 expression analysis were derived from matings of NMRI wild-type mice. Tbx18 Cre/+ ;Sox9 flox/flox (Sox9KO) mice were obtained from matings of Tbx18 Cre/+ ;Sox9 flox/+ males and Sox9 flox/flox females. Single heterozygous littermates were used as controls for mutant embryos. Tbx18 Cre/+ ;Rosa26 LacZ/LacZ mice were obtained from matings of Tbx18 Cre/+ ;R26 LacZ/+ males and R26 LacZ/LacZ females. For timed pregnancies, vaginal plugs were checked in the morning after mating, noon was taken as embryonic day (E) 0.5. Embryos were dissected in phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde (PFA) in PBS. Genomic DNA prepared from yolk sacs or tail biopsies was used for genotyping by PCR. AKO1110 sense primer (5′-CAGATCTCGGGAGGCATCG-3′) and AKO1111 antisense primer (5′-ATTCTCCCACCGTCAGTACG-3′) amplified a 723 bp fragment from the Tbx18 C r e allele. The oligos AKO0917/R1295 (5′-GCGAA-GAGTTTGTCCTCAACC-3′), AKO0918/R523 (5′-GGAGCGGGAGAAATG-GATATG-3′) and AKO0919/R26F2 (5′-AAAGTCGCTCTGAGTTGTTAT-3′) were used in a multiplex PCR and amplified a 500 bp fragment from the Rosa26 wild-type allele and a 250 bp fragment from the LacZ allele, respectively. AKO0745 (5′-CCGGCTGCTGGGAAAGTATATG-3′), AKO0746 (5′-CGCTGGTATTCAGGGAGGTACA-3′), and AKO0747 (5′-CTCCGGTAGCAAAGGCGTTTAG-3′) amplified a 247 bp fragment from the Sox9 wild-type allele and 419 bp/314 bp fragments from Sox9 flox / Sox9 del alleles.
Details on PCR conditions are available on request.
Histological analysis and 3-D reconstruction
Embryos were embedded in paraffin wax, sectioned to 5 or 10 µm and stained with Hematoxylin and Eosin (5 µm) or Alcian blue and Eosin (10 µm). For Alcian blue staining deparaffinized and rehydrated sections were incubated for 30 min in freshly filtrated Alcian blue solution (pH2.5, 1 g Alcian Blue 8GX (Sigma) per 100 ml 3% acetic acid), washed in PBS and counterstained with Eosin. 3-D reconstructions of Alcian blue stained serial sections were performed according to published protocols (Soufan et al., 2003) .
RNA in situ hybridization analysis
RNA in situ hybridization analysis on 10 µm paraffin sections was performed following a standard procedure with digoxigenin-labeled antisense riboprobes (Moorman et al., 2001) . Probes used were as follows: Aggrecan (NM_007424, Pos. 205-1167), Axin2 Car3 (AK003671, Pos. 64-1722), Coch (BC045137, Pos. 151-2480), Col2a1 (Cheah et al., 1991) , Col9a1 (AK031071, Pos. 1420-3405), Cre (X03453, Pos. 474-1518), Cx26 (NM_008125, Pos. 257-937), Dct (Baxter and Pavan, 2003) , LacZ (L08936, Pos. 3647-6691), Lfng (Zhang and Gridley, 1998) , Myo7a (AK052607, Pos. 1-2853), Otx2 (Simeone et al., 1992) , P27 (NM_009875, Pos. 646-1175), Pea3 (NM_008815, Pos. 1-2336), Pds (Everett et al., 1999) , Postn (AK30756 Pos. 1010-3202), Pou3f4 (Minowa et al., 1999) , Ptch1 (NM_008957, Pos. 1-4305), Sox9 , Rarb (NM_011243, approx. Pos. 1-1675), Tbx1 (Hou et al., 2007) , and Tbx18 (Kraus et al., 2001) .
Immunohistochemistry
For the immunohistochemical detection of Sox9 protein on 5 µm paraffin sections we used a polyclonal rabbit antiserum (a kind gift from Gerd Scherer, Freiburg) in a dilution of 1:200 and kits from Vector Laboratories (Vectastain ABC peroxidase kit (Rabbit IgG), DAB substrate kit). Phosphorylated (P-)Smad proteins were detected on 5 µm paraffin sections using polyclonal rabbit-anti-P-Smad1/5/ 8 (Cell Signalling, #9511, 1:100) and goat-anti-P-Smad2/3 (Santa Cruz, sc-11769, 1:100) primary antibodies, biotin-SP-conjugated secondary antibodies (Dianova, 111-065-003 and 705-065-003, 1:250) and the TSA Tetramethylrhodamine amplification kit (Perki-nElmer). Labeling with primary antibodies was performed at 4°C overnight after antigen retrieval (Sox9: 2 mM EDTA in 0.01 M Tris-HCl, pH9, at 80°C, 1 h; P-Smads: Antigen Unmasking Solution, Vector Laboratories, 5 min pressure cooker), blocking of endogenous peroxidases with 3% H 2 O 2 /PBS for 10 min and incubation in 2.5% normal goat serum for 30 min in PBST (Sox9) or blocking buffer provided from the TSA kit.
Cellular assays
Cell proliferation rates in tissues of E12.5 wild-type and Sox9KO embryos (three each) were investigated by the detection of incorporated BrdU on 5 µm paraffin sections according to published protocols (Bussen et al., 2004) . For each specimen five adjacent sections of the basal or apical cochlear region, respectively, were assessed. The BrdU-labeling index was defined as the number of BrdU-positive nuclei relative to the total number of nuclei as detected by 4′,6-Diamidino-2-phenylindole (DAPI) counterstaining in arbitrarily defined regions. Statistical analysis was performed using the two-tailed Student's t-test. Data were expressed as mean ± standard deviation. Differences were considered significant (*) when the Pvalue was below 0.05, and highly significant (**) when the P-value was below 0.01. Apoptosis in tissues was assessed by TUNEL assay using the ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon) on 5 µm paraffin sections. All sections were counterstained with DAPI.
Documentation
Sections were photographed using a Leica DM5000 microscope with a Leica DFC300FX digital camera. All images were processed in Adobe Photoshop CS.
Results
Sox9 is expressed in the periotic mesenchyme of the developing inner ear
Previous analyses have demonstrated Sox9 expression in the otocyst (Barrionuevo et al., 2008; Mak et al., 2009) and in the mesenchymal compartment of the inner ear during selected stages of mouse development (Kanzler et al., 1998; Trowe et al., 2008; Mak et al., 2009 ). To provide a detailed Sox9 expression profile during murine inner ear development, we performed RNA in situ hybridization analysis on transverse and sagittal sections of mouse heads from the onset of otic mesenchymal condensation to the beginning of otic fibrocyte differentiation ( Fig. 1 ). No mesenchymal expression was detected at E9.5 (data not shown). At E10.5, Sox9 expression was strong in the ventro-lateral region of the mesenchyme surrounding the otic vesicle, weaker in the medial aspect that extended into the cranial mesenchyme, and absent dorsally ( Fig. 1A) . At E11.5, Sox9 transcript levels were consistently high throughout the periotic mesenchyme ( Fig. 1B) , but at E12.5, Sox9 expression became gradually restricted to the outer mesenchymal compartment that gives rise to the otic capsule (Figs. 1C-D). From E15.5 onwards, Sox9 was down-regulated in this domain (data not shown) but expression was newly initiated in the condensing mesenchymal cells of the developing Stria vascularis and the spiral limbus that derive from the inner periotic mesenchyme compartment (Figs. 1E and F). Hence, Sox9 may play a role in the early condensation of the otic mesenchyme, in chondrogenic differentiation of the outer mesenchymal compartment and/or in the condensation of fibrocytes that underlie the developing Stria vascularis.
Conditional inactivation of Sox9 in the mesenchymal compartment of the inner ear
Since Sox9-deficiency results in early embryonic lethality in mice (Akiyama et al., 2004) , we employed a tissue-specific inactivation approach using a Tbx18 Cre line generated in our laboratory to analyze Sox9 function in the periotic mesenchyme. The T-box transcription factor gene Tbx18 is transiently expressed in the paraxial head mesoderm from E8.0 to E10.5 (Kraus et al., 2001) . From E12.5 to E18.5, Tbx18 expression is restricted to periotic mesenchymal cells that lie adjacent to the otic epithelium and will eventually differentiate into otic fibrocytes (Trowe et al., 2008) . Reporter gene analysis using ROSA26 LacZ mice demonstrated that Cre expression from the Tbx18 locus mediates extensive recombination in the entire periotic mesenchyme at E10.5 (Fig. 2B) , and in mesenchymal precursor cells of both the prospective inner (fibrocyte) and outer (capsule) compartments at E14.5 ( Fig. 2D ). Thus, despite restricted expression of Tbx18/Cre in the inner compartment of the otic mesenchyme (Figs. 2A and C), widespread expression of Tbx18 in the early cranial paraxial mesoderm, results in Tbx18 Cre mediated recombination in the entire periotic mesenchyme.
Tbx18 Cre/+ ;Sox9 flox/flox (Sox9KO) mice were born in a normal Mendelian ratio, but died shortly after birth for unknown reasons. The absence of Sox9 mRNA expression and dramatic reduction of Sox9 positive cells in the periotic mesenchyme of the cochlea in Sox9KO embryos at E10.5 and the absence of both mRNA and protein at E12.5 substantiate the suitability of this genetic approach to analyze Sox9 function in the cochlea of the inner ear (Figs. 2E-H, Supplemental  Fig. 2 ). Due to incomplete recombination in the vestibular (dorsal) portion of the inner ear (arrows in Fig. 2H ), the phenotypic alterations in this compartment were not further analyzed.
Otic capsule differentiation and cochlear duct coiling are severely disrupted in inner ears of Sox9KO embryos Histological analysis of Sox9KO inner ears at E18.5 indicated dramatic morphological abnormalities of the cochlea affecting both the mesenchymal cell compartment in which Sox9 was specifically inactivated and the epithelium of the cochlear duct (Figs. 3A-D). The total space occupied by otic tissue was severely reduced, whereas the loose connective tissue surrounding the Eustachian tube was expanded ( Fig. 3B, asterisk) . The Scala media was normally developed, however, the Scala vestibuli remained rudimentary and the Scala tympani did not form at all (Fig. 3B ). The mesenchyme between the epithelium of the cochlear duct and the branch of the internal carotid artery, i.e. the prospective mesenchyme of the lateral wall, appeared compact and did not exhibit any obvious compartmentalization (Fig. 3D ). In contrast, larger, round cells of the spiral limbus were clearly distinguishable from the surrounding connective tissue ( Fig. 3D ), indicating that Sox9 is required for the normal development of the lateral wall but dispensable for the differentiation of otic fibrocytes in the central cochlear region.
Most of the cartilaginous otic capsule tissue was absent in the cochlear region ( Fig. 3B ) of Sox9KO mice at E18.5, a finding that was confirmed by Alcian blue staining of deposited cartilaginous extracellular matrix (ECM) (Fig. 3F ). The otic capsule of the vestibular region appeared partially reduced (arrowheads in Figs. 3F and H) compatible with the finding of incomplete Cre-mediated Sox9 inactivation in the dorsal portion of the otic mesenchyme ( Fig. 2B) . We also noted a severe alteration of cochlear duct coiling in Sox9KO embryos (Fig. 3B ). Although the basal turn was present, visualization of cochlear duct morphology by 3D-reconstruction from serial histological sections revealed an irregularly shaped structure featuring 1.0 instead of 1.7 turns. In addition, the apex of the cochlear duct was oriented dorsally rather than in its normal ventral direction (Figs. 3H, J and L). These results show that loss of Sox9 expression in the periotic mesenchyme impairs the correct formation of the otic capsule, affects the otic fibrocyte compartment, and surprisingly, disrupts morphogenesis of the cochlear duct.
Minor gene expression changes in Sox9KO cochlear ducts indicate normal patterning and differentiation of the otic epithelium
Loss of mesenchymal Sox9 expression might not only alter the morphology but also affect differentiation of the otic epithelium. A detailed histological examination of the deformed cochlear duct revealed the presence of epithelial sub-compartments including Reissner's membrane, lateral wall and sensory epithelium (Figs. 4A and B) . Molecular characterization of the differentiation status of epithelial cells by RNA in situ hybridization analysis at E18.5 confirmed and extended these histological findings (Figs. 4C-O) . The homeobox transcription factor gene orthodenticle homolog 2 (Otx2) was normally expressed in Reissner's membrane of wild-type and Sox9KO inner ears (Figs. 4C and D) . Expression of the Bartter syndrome, infantile, with sensorineural deafness gene (Bsnd), that encodes a chloride channel subunit, in the adjacent lateral wall indicated normal differentiation of marginal cells of the Stria vascularis in Sox9KO embryos (Figs. 4E and F) Estevez et al., 2001) . Pds, encoding the ion transporter solute carrier family 26 member 4, Slc26a4, is expressed in epithelial cells of the outer sulcus (Everett et al., 1999) . In the Sox9 mutant, the spatial context of Pds expression between the Stria vascularis (Bsnd-positive) and the supporting cells (P27-positive) was maintained but the domain was significantly reduced in size. In addition, ectopic expression of Pds was found at the base of Reissner's membrane adjacent to interdental cells (Fig. 4H, white arrow) . Expression of P27 (also known as cyclin-dependent kinase inhibitor 1B, Cdkn1b) that marks the supporting cells of the pro-sensory epithelium (Chen and Segil, 1999) , of Bmp4 in Hensen and Claudius cells (Morsli et al., 1998) and of myosin VIIA (Myo7a) in outer and inner hair cells (Hasson et al., 1995) was unchanged ( Figs. 4I-N) , indicating normal differentiation of other sub-regions of the otic epithelium. In conditional Tbx1-mutant mice a loss of hair cells was found in the apical region of the cochlear duct (Xu et al., 2007) . However, normal expression of P27 and Myo7aA in the apical region of the cochlear duct showed that these cells are present in Sox9KO embryos (Supplemental Fig. 3) .
Thus, Sox9 and Sox9-dependent processes in the periotic mesenchyme are not essential for the patterning of the cochlear duct but are rather required to fine-tune epithelial differentiation (Fig. 4O) .
Differentiation of the periotic mesenchyme is impaired in Sox9-deficient inner ears
Histological analysis of Sox9-deficient inner ears had revealed an expansion of loose connective tissue at the expense of the otic capsule and otic fibrocytes (Fig. 3B ). We used RNA in situ hybridization analysis of marker genes to further assess compartmentalization and differentiation of the periotic mesenchyme in Sox9KO embryos at E18.5 (Fig. 5 ). Otic fibrocyte markers Pou3f4 and Tbx18 were expressed in a thin seam of mesenchyme adjacent to the cochlear duct indicating a lack of mesenchymal expansion (Figs. 5B and D). Expression of the Car3 gene, that encodes carbonic anhydrase III, was confined to spiral ligament fibrocytes in wildtype but was absent in Sox9KO embryos suggesting mis-differentiation of Tbx18/Pou3f4 positive otic fibrocytes in this region (Figs. 5E and F). Expression of the coagulation factor C homolog (Coch), which is restricted to the spiral limbus and a proximal region of the otic mesenchyme underlying the epithelium of the lateral wall in the wild-type at this stage, was only present in the spiral limbus region of the mutant (Figs. 5G and H). Expression of Connexin26 (Cx26), also known as gap junction protein, beta 2 (Gjb2) and of E-Cadherin, normally restricted to condensing mesenchymal cells underlying the Stria vascularis, was absent from the periotic mesenchyme of Sox9KO embryos (Figs. 5I and J and data not shown). Collectively, these findings argue that otic fibrocytes of the lateral wall fail to differentiate whereas properties of spiral limbus fibrocytes are still maintained in the Sox9KO inner ear.
Expression of the dopachrome tautomerase gene (Dct) that marks intermediate cell precursors of the Stria vascularis (Steel et al., 1992) appeared unchanged in the mutant indicating that migration of neural crest cells from which these cells derive occurred normally (Fig. 5L) . Notably, we found loss of Col2a1 and ectopic expression of Periostin (Postn) in the outer mesenchymal compartment of the Sox9KO cochlea indicating that otic capsule was replaced by fibrous connective tissue ( Figs. 5N and P) . Col2a1 expression was maintained in the mesenchymal seam adjacent to the epithelium confirming a heterogeneous architecture of the periotic mesenchyme in the mutant with Sox9-independence of Col2a1 expression in this region (Fig. 5N ). Together, these results show that loss of mesenchymal Sox9 expression leads to impaired growth and differentiation of the periotic mesenchyme into fibrocytes and capsule tissue and to abnormal formation of the mesenchymal cavities (Fig. 5R) . Sox9 regulates chondrocyte differentiation in the outer compartment of the otic mesenchyme but not the initial condensation and patterning of this tissue Sox9 is strongly expressed throughout the periotic mesenchyme, before expression is gradually restricted to the outer compartment that gives rise to the otic capsule at E12.5. We therefore wondered whether the observed mesenchymal differentiation defects might be caused, or at least be affected, by a failure in early recruitment and condensation, and/or the compartmentalization of the periotic mesenchyme.
Histological analysis of the E11.5 Sox9KO cochlea showed a normal outgrowth of the cochlear duct but the surrounding periotic mesenchyme appeared less condensed (Figs. 6A and B) . Expression of Col2a1 and collagen type IX, alpha 1 (Col9a1) that encode ECM proteins mainly present in chondrogenic tissues and cartilage, was absent (Col2a1) or strongly reduced (Col9a1), respectively, in the cochlear periotic mesenchyme (Figs. 6C and D, data not shown). Expression of Tbx1 was reduced in the ventral periotic mesenchyme ( Figs. 6E, F, arrow) . Histological analysis of mutant cochlea at E12.5 revealed a thickened otic epithelium with increased diameter of the cochlear duct and a reduction of the surrounding periotic mesenchyme. However, the otic mesenchyme showed normal condensation and subdivision into an inner and outer compartment with low and high cell density, respectively (Figs. 6G and H) . Compartmentalization of the Pou3f4-positive periotic mesenchyme was confirmed by restriction of Tbx18 expression to the inner compartment in Sox9 mutants (Figs. 6I and L) . Expression of Col2a1 and Col9a1 was absent in the outer and reduced in the inner compartment of the periotic mesenchyme (Figs. 6M-P). Expression of Tbx1 that is co-expressed with Sox9 in the outer compartment at this stage was strongly downregulated in Sox9KO embryos (Figs. 6Q and R) . At E13.5, i.e. at the onset of chondrocyte differentiation in the outer ring of the periotic mesenchyme, deposition of cartilagenous proteoglycans as assessed by Alcian blue staining was already diminished in Sox9KO embryos (Figs. 6S and T) . At E15.5, Sox9KO embryos exhibited a rudimentary developed cartilagenous otic capsule in the cochlear region ( Figs. 6U and V) . Together, these data exclude a role for Sox9 in the early condensation and compartmentalization of the periotic mesenchyme. However, Sox9 is required for recruitment and/or expansion of these cells, and chondrocyte differentiation in the outer mesenchymal compartment.
Broadening of the cochlear duct increased after E12.5 (Figs. 6S and T) , and from E13.5 onwards coiling morphogenesis was severely impaired in Sox9 mutants (Figs. 6W-Z) , arguing that epithelial defects are not a late consequence of Sox9-deficiency in the periotic mesenchyme but are closely associated with the early mesenchymal changes.
Sox9 regulates cell proliferation in the periotic mesenchyme and in the epithelium of the cochlear duct
Abnormal coiling morphogenesis of the cochlea and reduced expansion of mesenchymal compartments in the inner ear of Sox9 mutants suggested impaired cell proliferation and/or apoptosis of precursor cells. Indeed, we observed an overall size reduction of the cochlea at E12.5 (Fig. 3B) . We assessed the relative proliferation of mesenchymal and epithelial compartments in Sox9KO inner ears at this stage, i.e. prior to the manifestation of the severe morphological abnormalities. For this analysis, we defined two mesenchymal domains at the apical region of the cochlear duct and three epithelial regions (basal, medial and apical) that were further subdivided into pro-sensory and non-sensory areas (Figs. 7A-D) . The overall proliferation rate in the periotic mesenchyme of Sox9KO embryos was decreased by 32%. In the pro-sensory epithelium we found a reduction of 22% (basal) and 51% (medial), respectively. In the apical, non-sensory epithelium, we detected a 43% increase in proliferation (Fig. 7E ). Assessment of apoptosis by the TUNEL assay, in contrast, did not reveal any alterations in cell survival at this stage (Figs. 7F and G) . We conclude that Sox9 is involved in proliferation control and the proper expansion of the early mesenchymal compartment. Moreover, the results show a Sox9-dependent role of the periotic mesenchyme in controlling the proliferation rate of the epithelial cochlear duct cells.
In an attempt to further understand the molecular and cellular mechanisms underlying the morphological defects of the otic epithelium in Sox9KO embryos, we analyzed the activity of a number of signaling pathways known to play important roles in mesenchymal-epithelial tissue interactions. For Wnt/ß-Catenin-signaling we screened for expression of the universal target gene Axin2 (Jho et al., 2002) by in situ hybridization analysis on sections of E11.5 and E12.5 Sox9KO inner ears. Similarly, we analyzed expression of patched homolog 1 (Ptch1) for Hedgehog-, retinoic acid receptor beta (Rarb) for retinoic acid-and ets variant gene 4 (Etbv4, Pea3) for Fgf-signaling (Goodrich et al., 1996; Rossant et al., 1991; Tsou et al., 1994; Hayashi et al., 2008) . To investigate a role of Bmp-and TGFß-signaling, we analyzed the expression of the intracellular mediators Phospho-Smad1/5/8 and Phospho-Smad2/3 (Miyazawa et al., 2002) by immunofluorescence. Expressions of Axin2, Ptch1, Rarb and Pea3, and of Phospho-Smad1/5/8 and Phospho-Smad2/3 were not changed in the otic epithelium of Sox9KO inner ears at these stages suggesting that neither canonical Wnt nor Hedgehog, retinoic acid, Fgf, Bmp or Tgfß signals act downstream of Sox9 in the otic mesenchyme to control cochlea morphogenesis (Supplemental Fig. 4 ).
Discussion
The genetic pathways that regulate the differentiation of the periotic mesenchyme in the inner ear and coordinate mesenchymal development with that of the epithelial cochlear duct have been poorly defined. This study demonstrates that Sox9 is a key factor in regulating differentiation and expansion of otic fibrocytes, formation of the endochondral capsule and cochlear duct coiling. Whereas the first two processes are likely to reflect a cell-autonomous requirement for Sox9, the latter provides evidence for the necessity of the mesenchymal inner ear compartment for normal morphogenesis of the otic epithelium.
Sox9 regulates otic capsule formation
Development of the otic capsule occurs by endochondral ossification, i.e. a mesenchymal matrix gives rise to a cartilaginous template that is subsequently replaced by bone tissue (Sher, 1971) . Chondrogenesis progresses through distinct cellular programs including cell sorting, aggregation and compaction of mesenchymal progenitors followed by overt chondrocyte differentiation (Hall and Miyake, 2000) . Inactivation of Sox9 in developing limb mesenchyme leads to complete loss of the cartilagenous pre-skeleton defining this transcription factor as an essential regulator of chondrogenesis (Akiyama et al., 2002) . In vitro studies have shown that Sox9 is not required for initial formation of mesenchymal cell condensations but for their maintenance and subsequent chondrocyte differentiation (Bi et al., 1999; Barna and Niswander, 2007; Hargus et al., 2008) . Our finding that compaction of mesenchymal cells in the outer compartment of the periotic mesenchyme occurs in Sox9KO embryos but that deposition of a cartilaginous matrix fails shortly thereafter supports the idea that Sox9 plays a very similar role in the development of the otic capsule. Expression of Periostin in Sox9-deficient mesenchymal cells is compatible with the earlier notion that these cells differentiate into non-otic fibrocytes rather than into chondrocytes. Sox9 function in otic capsule formation may be partly mediated by Tbx1, the expression of which is strongly down-regulated in the outer compartment of the Sox9-deficient periotic mesenchyme at E12.5. In support of these findings, inactivation of Tbx1 in the periotic mesenchyme results in partial formation of the otic capsule, a defect that was suggested to arise from reduced cell proliferation in the periotic mesenchyme (Xu et al., 2007) . However, pathways regulated by Sox9 and Tbx1 are possibly different since Pou3f4 expression in the periotic mesenchyme is only affected by loss of Tbx1 (Braunstein et al., 2008; Braunstein et al., 2009 ) but not of Sox9.
Sox9 is required for differentiation and expansion of otic fibrocytes
In addition to the arrest of chondrogenesis in the otic capsule, development of otic fibrocytes from the inner mesenchymal compartment was severely perturbed upon Sox9 inactivation in the periotic mesenchyme. The number of fibrocytes was reduced, differentiation of lateral wall cell subtypes failed and perilymphatic spaces were only partially established. Since Sox9 is transiently expressed in precursors of otic fibrocytes at early condensation stages (E10.5-E11.5), these defects may arise from a cell-autonomous requirement of Sox9 in this tissue. Indeed, we detected expression changes of genes encoding ECM components including Col2a1 and Col9a1 as early as E11.5 in the entire periotic mesenchyme. Furthermore, cellular expansion of both mesenchymal compartments was severely affected at E12.5 suggesting an early function of Sox9 in regulating the proliferation of mesenchymal progenitors. Similarly, Sox9 has been shown to control cell-autonomously proliferation to maintain a progenitor cell pool during pancreas development (Seymour et al., 2007) . In Sox9-deficient periotic mesenchyme, proliferative defects may at least partly be caused by downregulation of Tbx1 that is expressed in a similar pattern as Sox9 in the periotic mesenchyme from E10.5 to E11.5 (Vitelli et al., 2003; Xu et al., 2007, Figs. 1B and 6Q) .
Alternatively, otic fibrocyte development may not directly depend on Sox9 function but may be influenced by signals from chondrogenic mesenchymal precursors in the adjacent compartment. The specific role of Sox9 in regulating the development of the inner compartment of the periotic mesenchyme may be clarified by conditional Sox9 inactivation in the periotic mesenchyme after E11.5 when Sox9 is no longer expressed in precursors of otic fibrocytes.
Sox9 is required for cochlear duct outgrowth and coiling morphogenesis
Growth and coiling morphogenesis of the cochlea rely on a precise spatiotemporal coordination of cell proliferation and cellular rearrangements within the otic epithelium (Lang et al., 2000; McKenzie et al., 2004; Kelly and Chen, 2007;  for review see also Bok et al. (2007) ). This program is intrinsic to the epithelium but is also influenced by signals from the surrounding mesenchyme (Miura et al., 2004) .
A pioneering morphological study suggested that the otic capsule constitutes a physical barrier that confines cochlear outgrowth and thereby causes the coiling process (Li and McPhee, 1978; Li and McPhee, 1979) . However, the findings that inactivation of a number of genes, e.g. Pou3f4 and Tbx1, from the pericochlear mesenchyme disrupts cochlear morphogenesis (Phippard et al., 1999; Xu et al., 2007) have recently highlighted the importance of signaling from the otic mesenchyme to the cochlear epithelium. Our findings that the loss of Sox9 in the periotic mesenchyme causes severe defects in the morphogenesis of the cochlear duct, supports the notion that cochlear coiling is not simply the result of physical constraints imposed by a cartilaginous template but relies on the co-ordinated interaction between the epithelial and mesenchymal compartments of the cochlea throughout development. Alterations in epithelial proliferation, thickening of the otic epithelium and increase of cochlear duct diameter in Sox9KO embryos at E12.5, demonstrate the necessity of mesenchymal signals for epithelial morphogenesis already at precartilagenous stages. Therefore, Sox9 may directly regulate these signals for cochlear duct outgrowth at this stage.
At present, the molecular identity of these mesenchymal factors is unknown. Our study excluded a number of signaling pathways known in tissue interactions including Wnt/ß-Catenin, Fgf, Bmp, TgFß, retinoic acid and Hedgehog to act downstream of Sox9 in the otic mesenchyme in the control of cochlear morphogenesis. In addition to secreted proteins, ECM components including collagens may control cochlear outgrowth. Collagens provide integrity and elasticity to developing tissues, mediate cell adhesion and epithelial morphogenesis (for reviews see Heino (2007) and Rozario and Desimone (2009) ) and constitute central components of the ECM of the developing periotic mesenchyme and its derivatives (Van De Water and Galinovic-Schwartz, 1987; Berggren et al., 1997; Shpargel et al., 2004; Asamura et al., 2005) . In particular, Collagen II deposition is remarkably increased during periotic mesenchyme condensation at E12.5 (D'Amico- Martel et al., 1987) and disruption of its spatiotemporal distribution pattern alters morphogenesis of the inner ear (Van De Water and Galinovic-Schwartz, 1987). Sox9 is a known regulator of ECM composition, by directly activating the transcription of Col genes such as Col2a1, Col4a2 and Col9a1 (Bell et al., 1997; Zhang et al., 2003; Genzer and Bridgewater, 2007; Sumi et al., 2007) . Reduced expression of Col2a1 and Col9a1 in the periotic mesenchyme at E12.5 in the Sox9 mutant suggests that aberrant coiling morphogenesis is at least partially due to a loss of Sox9 function in modulating the composition of the ECM of the periotic mesenchyme. The ECM is critically involved in mediating the transport, storage, degradation and binding of growth factors to respective receptors (for reviews see Rozario and Desimone (2009) and Tsang et al. (2010) ). Interestingly, the adjacent hindbrain has been identified as an important source for growth factors such as Sonic hedgehog (Shh), Wnt1, and Wnt3a that influence the development of the otic epithelium in mice (Riccomagno et al., 2002; Riccomagno et al., 2005 ; also reviewed in Bok et al. (2007) and Schneider-Maunoury and Pujades (2007)). A series of tissue transplantation experiments in chicken embryos also suggested the existence of rhombomere specific, yet unidentified, signaling factors that are required for cochlear growth and morphogenesis (Liang et al., 2010) . It is therefore possible that the phenotypes observed in the Sox9KO mutant reflect the consequence of an aberrant communication between the hindbrain and the otic epithelium.
The mild gene expression changes in the cochlear epithelium of Sox9KO mutants, strongly argue that major patterning events of the otic vesicle and the early cochlear duct occur independently from Sox9 (-dependent processes) in the surrounding mesenchyme. Finetuning, in contrast, may occur later upon interaction with the periotic mesenchyme. Aberrant differentiation of sensory cells, as reported for mesenchyme-specific Tbx1KO mice (Xu et al., 2007) , was not detected in Sox9KO mutants. This suggests that mesenchymal Tbx1 expression controls signaling pathways that establish or maintain the sensory epithelium independent from Sox9 in the early periotic mesenchyme, and excludes a major role for the otic capsule and otic fibrocytes in epithelial differentiation.
In conclusion, this study demonstrates that Sox9 is an essential regulator of differentiation and expansion of otic fibrocytes, formation of the otic capsule and cochlear duct coiling and provides a new mouse model to demonstrate the intimate interaction of mesenchymal and epithelial compartments during the development of the inner ear.
